The value of systematic biopsies in screening for prostate cancer with PSA followed by MRI - results from the GOTEBORG prostate cancer screening 2 trial

被引：0
|
作者：
Kohestani, K. [1 ]
Godtman, Arnsrud R. [1 ]
Axcrona, U. [2 ]
Egevad, L. [3 ]
Hellstrom, M. [4 ]
Khatami, A. [1 ]
Pihl, C-G [5 ]
Stranne, J. [1 ]
Wallstrom, J. [4 ]
Mansson, M. [1 ]
Carlsson, S., V [6 ]
Hugosson, J. [1 ]
机构：
[1] Gothenburg Univ, Sahlgrenska Acad, Dept Urol, Inst Clin Sci, Gothenburg, Sweden
[2] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway
[3] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden
[4] Gothenburg Univ, Dept Radiol, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden
[5] Gothenburg Univ, Sahlgrenska Acad, Dept Pathol, Inst Biomed, Gothenburg, Sweden
[6] Mem Sloan Kettering Canc Ctr, New York Mem, Dept Urol, Surg Urol Serv,Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA
来源：
EUROPEAN UROLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0364
引用
收藏
页码：S565 / S565
页数：1
相关论文
共 50 条
  • [41] RESULTS FROM THE GOTHENBURG RANDOMISED PROSTATE CANCER SCREENING TRIAL
    Hugosson, J.
    Aus, G.
    Bergdahl, S.
    Carlsson, S.
    Khatami, A.
    Lodding, P.
    Stranne, J.
    Holmberg, E.
    Lilja, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 37 - 37
  • [42] PROSTATE CANCER SCREENING Disinvesting from prostate cancer screening
    Wilson, Nick
    BRITISH MEDICAL JOURNAL, 2011, 343
  • [43] Diagnostic Effects of Omitting Systematic Biopsies in Prostate Cancer Screening
    Engel, Jan Chandra
    Eklund, Martin
    Jaderling, Fredrik
    Palsdottir, Thorgerdur
    Falagario, Ugo
    Discacciati, Andrea
    Nordstrom, Tobias
    EUROPEAN UROLOGY ONCOLOGY, 2025, 8 (02): : 435 - 443
  • [44] The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Goteborg-1 Prostate Cancer Screening Trial
    Godtman, Rebecka Arnsrud
    Kollberg, Karin Stinesen
    Pihl, Carl-Gustaf
    Mansson, Marianne
    Hugosson, Jonas
    EUROPEAN UROLOGY, 2022, 82 (03) : 311 - 317
  • [45] Re: Reconsidering Prostate Cancer Mortality - The Future of PSA Screening The future of PSA screening by reconsidering prostate cancer mortality
    Borghesi, Marco
    Suardi, Nazareno
    Terrone, Carlo
    EUROPEAN UROLOGY, 2020, 78 (06) : 929 - 929
  • [46] Prostate Cancer and PSA Among Statin Users in the Finnish Prostate Cancer Screening Trial Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 184 (01): : 175 - 176
  • [47] Outcome Following Surveillance of Men with Screen-Detected Prostate Cancer: Results from the Goteborg Randomized Population-Based Prostate Cancer Screening Trial
    Hugosson, J.
    Godtman, R.
    Khatami, A.
    Stranne, J.
    UROLOGY, 2012, 80 (03) : S25 - S26
  • [48] Results of the second screening round of the Finnish prostate cancer screening trial
    Tammela, TL
    Määttänen, L
    Stenman, UH
    Rannikko, S
    Juusela, H
    Aro, J
    Hakama, M
    Auvinen, A
    JOURNAL OF UROLOGY, 2002, 167 (04): : 100 - 100
  • [49] False positive screening results in the finnish prostate cancer screening trial
    Kilpelaeinen, T.
    Tammela, T. L.
    Martikainen, P.
    Maeaetlaenen, L.
    Auvinen, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 199 - 199
  • [50] Prostate cancer and prostate specific antigen (PSA) screening in Austria
    Vutuc, C
    Schernhammer, ES
    Haidinger, G
    Waldhör, T
    WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (13-14) : 457 - 461
12345